Maureen K. Hahn - Publications

Affiliations: 
Vanderbilt University, Nashville, TN 
Area:
catecholamines, norepinephrine transporter, psychiatric disorders

30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Stewart A, Davis GL, Gresch PJ, Katamish RM, Peart R, Rabil MJ, Gowrishankar R, Carroll FI, Hahn MK, Blakely RD. Serotonin transporter inhibition and 5-HT receptor activation drive loss of cocaine-induced locomotor activation in DAT Val559 mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 30578419 DOI: 10.1038/s41386-018-0301-8  1
2018 Gowrishankar R, Gresch PJ, Davis GL, Katamish RM, Riele JR, Stewart AM, Vaughan RA, Hahn MK, Blakely RD. Region-Specific Regulation of Presynaptic Dopamine Homeostasis by D2 Autoreceptors Shapes the Impact of the Neuropsychiatric Disease-Associated DAT Variant Val559. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 29739866 DOI: 10.1523/JNEUROSCI.0055-18.2018  1
2017 Davis GL, Stewart A, Stanwood GD, Gowrishankar R, Hahn MK, Blakely RD. Functional Coding Variation in the Presynaptic Dopamine Transporter Associated with Neuropsychiatric Disorders Drives Enhanced Motivation and Context-Dependent Impulsivity in Mice. Behavioural Brain Research. PMID 28964912 DOI: 10.1016/j.bbr.2017.09.043  1
2015 Kohli U, Diedrich A, Kannankeril PJ, Muszkat M, Sofowora GG, Hahn MK, English BA, Blakely RD, Stein CM, Kurnik D. Genetic Variation in Alpha2-Adrenoreceptors and Heart Rate Recovery after Exercise. Physiological Genomics. physiolgenomics.0012. PMID 26058836 DOI: 10.1152/physiolgenomics.00124.2014  1
2014 Mergy MA, Gowrishankar R, Gresch PJ, Gantz SC, Williams J, Davis GL, Wheeler CA, Stanwood GD, Hahn MK, Blakely RD. The rare DAT coding variant Val559 perturbs DA neuron function, changes behavior, and alters in vivo responses to psychostimulants. Proceedings of the National Academy of Sciences of the United States of America. 111: E4779-88. PMID 25331903 DOI: 10.1073/pnas.1417294111  1
2014 Mergy MA, Gowrishankar R, Davis GL, Jessen TN, Wright J, Stanwood GD, Hahn MK, Blakely RD. Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorder. Neurochemistry International. 73: 56-70. PMID 24332984 DOI: 10.1016/j.neuint.2013.11.009  1
2014 Gowrishankar R, Hahn MK, Blakely RD. Good riddance to dopamine: roles for the dopamine transporter in synaptic function and dopamine-associated brain disorders. Neurochemistry International. 73: 42-8. PMID 24231471 DOI: 10.1016/j.neuint.2013.10.016  1
2013 Fentress HM, Klar R, Krueger JJ, Sabb T, Redmon SN, Wallace NM, Shirey-Rice JK, Hahn MK. Norepinephrine transporter heterozygous knockout mice exhibit altered transport and behavior. Genes, Brain, and Behavior. 12: 749-59. PMID 24102798 DOI: 10.1111/gbb.12084  1
2013 Ma Y, Krueger JJ, Redmon SN, Uppuganti S, Nyman JS, Hahn MK, Elefteriou F. Extracellular norepinephrine clearance by the norepinephrine transporter is required for skeletal homeostasis. The Journal of Biological Chemistry. 288: 30105-13. PMID 24005671 DOI: 10.1074/jbc.M113.481309  1
2013 Shirey-Rice JK, Klar R, Fentress HM, Redmon SN, Sabb TR, Krueger JJ, Wallace NM, Appalsamy M, Finney C, Lonce S, Diedrich A, Hahn MK. Norepinephrine transporter variant A457P knock-in mice display key features of human postural orthostatic tachycardia syndrome. Disease Models & Mechanisms. 6: 1001-11. PMID 23580201 DOI: 10.1242/dmm.012203  1
2013 Hahn MK, Shirey-Rice JK, Klar R, Fentress HM, Redmon SN, Sabb TR, Krueger JJ, Wallace NM, Appalsamy M, Finney C, Lonce S, Diedrich A, Robertson DH. Norepinephrine Transporter A457P Knockin Mice Display Tachycardia and Anxiety-Like Behavior Catecholamine Research in the 21st Century: Abstracts and Graphical Abstracts, 10th International Catecholamine Symposium, 2012. 38-39. DOI: 10.1016/B978-0-12-800044-1.00032-5  1
2012 Hahn MK. Norepinephrine Transporter Deficiency Primer On the Autonomic Nervous System. 439-442. DOI: 10.1016/B978-0-12-386525-0.00090-1  1
2012 Hahn MK. Antidepressant-Sensitive Norepinephrine Transporters. Structure and Regulation Primer On the Autonomic Nervous System. 49-50. DOI: 10.1016/B978-0-12-386525-0.00008-1  1
2011 Kohli U, Hahn MK, English BA, Sofowora GG, Muszkat M, Li C, Blakely RD, Stein CM, Kurnik D. Genetic variation in the presynaptic norepinephrine transporter is associated with blood pressure responses to exercise in healthy humans. Pharmacogenetics and Genomics. 21: 171-8. PMID 21412203 DOI: 10.1097/FPC.0b013e328344f63e  1
2009 English BA, Hahn MK, Gizer IR, Mazei-Robison M, Steele A, Kurnik DM, Stein MA, Waldman ID, Blakely RD. Choline transporter gene variation is associated with attention-deficit hyperactivity disorder. Journal of Neurodevelopmental Disorders. 1: 252-63. PMID 21547719 DOI: 10.1007/s11689-009-9033-8  1
2009 Hahn MK, Steele A, Couch RS, Stein MA, Krueger JJ. Novel and functional norepinephrine transporter protein variants identified in attention-deficit hyperactivity disorder. Neuropharmacology. 57: 694-701. PMID 19698724 DOI: 10.1016/j.neuropharm.2009.08.002  1
2008 Hahn MK, Blackford JU, Haman K, Mazei-Robison M, English BA, Prasad HC, Steele A, Hazelwood L, Fentress HM, Myers R, Blakely RD, Sanders-Bush E, Shelton R. Multivariate permutation analysis associates multiple polymorphisms with subphenotypes of major depression. Genes, Brain, and Behavior. 7: 487-95. PMID 18081710 DOI: 10.1111/j.1601-183X.2007.00384.x  1
2007 Hahn MK, Blakely RD. The functional impact of SLC6 transporter genetic variation. Annual Review of Pharmacology and Toxicology. 47: 401-41. PMID 17067279 DOI: 10.1146/annurev.pharmtox.47.120505.105242  1
2006 Kim CH, Hahn MK, Joung Y, Anderson SL, Steele AH, Mazei-Robinson MS, Gizer I, Teicher MH, Cohen BM, Robertson D, Waldman ID, Blakely RD, Kim KS. A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder. Proceedings of the National Academy of Sciences of the United States of America. 103: 19164-9. PMID 17146058 DOI: 10.1073/pnas.0510836103  1
2005 Nass R, Hahn MK, Jessen T, McDonald PW, Carvelli L, Blakely RD. A genetic screen in Caenorhabditis elegans for dopamine neuron insensitivity to 6-hydroxydopamine identifies dopamine transporter mutants impacting transporter biosynthesis and trafficking. Journal of Neurochemistry. 94: 774-85. PMID 15992384 DOI: 10.1111/j.1471-4159.2005.03205.x  1
2005 Hahn MK, Mazei-Robison MS, Blakely RD. Single nucleotide polymorphisms in the human norepinephrine transporter gene affect expression, trafficking, antidepressant interaction, and protein kinase C regulation. Molecular Pharmacology. 68: 457-66. PMID 15894713 DOI: 10.1124/mol.105.011270  1
2004 Hahn MK. Norepinephrine Transporter Dysfunction Primer On the Autonomic Nervous System: Second Edition. 280-282. DOI: 10.1016/B978-012589762-4/50076-1  1
2003 Cuajungco MP, Ando Y, Axelrod FB, Biaggioni I, Goldstein DS, Guttmacher AE, Gwinn-Hardy K, Hahn MK, Hilz MJ, Jacob G, Jens J, Kennedy WR, Liggett SB, O'Connor DT, Peltzer SR, et al. Hereditary dysautonomias: current knowledge and collaborations for the future. Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society. 13: 180-95. PMID 12822040 DOI: 10.1007/s10286-003-0098-2  1
2003 Hahn MK, Robertson D, Blakely RD. A mutation in the human norepinephrine transporter gene (SLC6A2) associated with orthostatic intolerance disrupts surface expression of mutant and wild-type transporters. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 4470-8. PMID 12805287  1
2002 Garland EM, Hahn MK, Ketch TP, Keller NR, Kim CH, Kim KS, Biaggioni I, Shannon JR, Blakely RD, Robertson D. Genetic basis of clinical catecholamine disorders. Annals of the New York Academy of Sciences. 971: 506-14. PMID 12438171  1
2002 Hahn MK, Blakely RD. Monoamine transporter gene structure and polymorphisms in relation to psychiatric and other complex disorders. The Pharmacogenomics Journal. 2: 217-35. PMID 12196911 DOI: 10.1038/sj.tpj.6500106  1
2000 Chang MS, Hahn MK, Sved AF, Zigmond MJ, Austin MC, Sherman TG. Analysis of tyrosine hydroxylase gene transcription using an intron specific probe. Journal of Neuroscience Methods. 94: 177-85. PMID 10661837 DOI: 10.1016/S0165-0270(99)00137-5  1
1999 Hahn MK, Bannon MJ. Stress-induced C-fos expression in the rat locus coeruleus is dependent on neurokinin 1 receptor activation. Neuroscience. 94: 1183-8. PMID 10625057 DOI: 10.1016/S0306-4522(99)00319-X  1
1998 Hahn MK, Bannon MJ. Tachykinin NK1 receptor antagonists enhance stress-induced c-fos in rat locus coeruleus. European Journal of Pharmacology. 348: 155-60. PMID 9652329 DOI: 10.1016/S0014-2999(98)00150-2  1
1996 D'Sa C, Hirayama K, West A, Hahn M, Zhu M, Kapatos G. Tetrahydrobiopterin biosynthesis in C6 glioma cells: induction of GTP cyclohydrolase I gene expression by lipopolysaccharide and cytokine treatment. Brain Research. Molecular Brain Research. 41: 105-10. PMID 8883940 DOI: 10.1016/0169-328X(96)00073-3  1
Show low-probability matches.